(23 days)
No
The 510(k) summary describes a mechanical hip implant system and its components. There is no mention of software, algorithms, image processing, AI, or ML. The performance studies are mechanical and structural tests, not related to data analysis or interpretation.
Yes
The device is a hip replacement system intended to treat various hip conditions, which is a therapeutic purpose.
No
This device is a total hip replacement system, used to replace a diseased or damaged hip joint. Its intended use is for treatment, not diagnosis.
No
The device description clearly indicates it is a hip implant system consisting of physical components (femoral hip stems, acetabular cup, modular heads). There is no mention of software as the primary or sole component.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the Apex Hip System is for "primary or revision total hip replacement." This is a surgical implant used in vivo (within the body) to replace a joint.
- Device Description: The description details components of a hip prosthesis (femoral hip stems, acetabular cup, modular heads). These are physical implants.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or compatibility testing.
IVD devices are used in vitro (outside the body) to analyze biological samples. The Apex Hip System is a surgical implant used in vivo.
N/A
Intended Use / Indications for Use
The Apex Hip System is intended for primary or revision total hip replacement. The femoral hip stems and acetabular cup are intended for uncemented fixation and single use implantation. These prostheses may be used for the following conditions, as appropriate:
- Non-inflammatory degenerative joint disease, including osteoarthritis and avascular necrosis;
- Rheumatoid arthritis;
- Correction of functional deformity;
- Congenital dislocation;
- Revision procedures where other treatments or devices have failed;
- Femoral neck and trochanteric fractures of the proximal femur.
Product codes
LPH
Device Description
Apex Modular Head sizes 28, 32, 36, and 40 mm with a + 10.5mm offset
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Hip
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Non-Clinical Test Summary
The following tests were conducted:
- ROM analysis per ISO-21565-2007 .
- Finite Element Analysis per ISO-7206-4 .
- Fatigue Strength Testing per ISO 7206-6,ASTM F2068-09 .
Clinical Test Summary
No clinical studies were performed.
Key Metrics
Not Found
Predicate Device(s)
K000788 Apex Modular Hip Stem, 28 and 32 mm heads, August 02.2000, K073150 ApeX-LNK Poly Acetabular Cup Liners and 36 mm Heads, February 27, 2008), K100555 ApeX-LNK Poly Acetabular Liners and Apex Modular Head, 40mm, March 29, 2010)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3358 Hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis.
(a)
Identification. A hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis is a device intended to be implanted to replace a hip joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across the joint. This generic type of device has a femoral component made of a cobalt-chromium-molybdenum (Co-Cr-Mo) alloy or a titanium-aluminum-vanadium (Ti-6Al-4V) alloy and an acetabular component composed of an ultra-high molecular weight polyethylene articulating bearing surface fixed in a metal shell made of Co-Cr-Mo or Ti-6Al-4V. The femoral stem and acetabular shell have a porous coating made of, in the case of Co-Cr-Mo substrates, beads of the same alloy, and in the case of Ti-6Al-4V substrates, fibers of commercially pure titanium or Ti-6Al-4V alloy. The porous coating has a volume porosity between 30 and 70 percent, an average pore size between 100 and 1,000 microns, interconnecting porosity, and a porous coating thickness between 500 and 1,500 microns. The generic type of device has a design to achieve biological fixation to bone without the use of bone cement.(b)
Classification. Class II.
0
K101575 (pg 1/2)
JUN 3 0 2010
Apex Modular Heads, +10.5mm offset
04June, 2010
Submitter OMNI life science, Inc. Contact 50 O'Connell Way E. Taunton MA 02718
Radhika Pondicherry Regulatory Affairs 774-226-1852 (508) 822-6030 (fax)
| Preparation Date | 04 June 2010 |
|---|---|
| Device Name | APEX Modular Head, +10.5mm offset |
| Trade Name | APEX Modular Head, +10.5mm offset |
| Common/Classification Name | Hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis |
| Regulatory Class | Class II per 21 CFR §888.3358 |
| Product Code | LPH |
| Legally Marketed Predicate Device(s) | K000788 Apex Modular Hip Stem, 28 and 32 mm heads, August 02.2000 K073150 ApeX-LNK Poly™ Acetabular Cup Liners and 36 mm Heads, February 27, 2008) K100555 ApeX-LNK Poly Acetabular Liners and Apex Modular Head, 40mm, March 29, 2010) |
| Device Description | Apex Modular Head sizes 28, 32, 36, and 40 mm with a + 10.5mm offset |
| Indications for Use | The Apex Hip System is intended for primary or revision total hip replacement. The femoral hip stems and acetabular cup are intended for uncemented fixation and single use implantation. These prostheses may be used for the following conditions, as appropriate: Non-inflammatory degenerative joint disease, including osteoarthritis and avascular necrosis; Rheumatoid arthritis; Correction of functional deformity; Congenital dislocation; Revision procedures where other treatments or devices have failed; Femoral neck and trochanteric fractures of the proximal femur. |
1
Predicate Device Comparison
| Apex Hip System, +10.5 offset (subject device) | Apex Modular femoral heads (K000788) (K073150) (K100555) | |
|---|---|---|
| Intended Use | ||
| Primary and revision total hip replacement | Yes | Yes |
| Design | ||
| Taper Design | Size "N" bore in ASTM F1636-95 | Size "N" bore in ASTM F1636-95 |
| Head Diameters | 28, 32, 36, 40 mm | 28, 32, 36, 40mm |
| Offsets (mm) | +10.5 | -3.5, +0, +3.5, +7 |
| Materials | ||
| Femoral Heads | Wrought cobalt chromium | Wrought cobalt chromium |
| Standards | ASTM F1537 | ASTM F1537 |
| PACKAGING AND STERILIZATION | ||
| Sterilization | Ethylene oxide | Ethylene oxide |
| Sal | $10^{-6}$ | $10^{-6}$ |
| Packaging | Paper Board Box, Double Tyvek inner pouch | Paper Board Box, Double Tyvek inner pouch |
Non-Clinical Test The following tests were conducted: Summary
- ROM analysis per ISO-21565-2007 .
- Finite Element Analysis per ISO-7206-4 .
- Fatigue Strength Testing per ISO 7206-6,ASTM F2068-09 .
Clinical Test Summary
No clinical studies were performed.
Conclusions
The Apex Modular Head is substantially equivalent to the predicate devices.
2
Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo is a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle or bird-like figure with three curved lines representing its wings or feathers.
JUN 3 0 2010
Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-0609 Silver Spring, MD 20993-0002
OMNIlife science, Inc. % Radhika Pondicherry Regulatory Affairs Specialist 50 O'Connell Way E.Taunton MA 02718
Re: K101575
Trade/Device Name: Apex Modular Head Size 28, 32, 36 and 40mm +10.5 offset Regulation Number: 888.3358 Regulation Name: Hip joint metal/polymer/metal semi-constrained porqus-coated uncemented prosthesis Regulatory Class: Class II Product Code: LPH Dated: June 4, 2010 Received: June 7, 2010
Dear Ms. Pondicherry:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must
3
Page 2 - Ms. Radhika Pondicherry
comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Mark N. Melkerson
Director Division of Surgical. Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number : K101575 (pg i/i)
Device Name: Apex Modular Head, +10.5mm offset
The Apex Hip System is intended for primary or revision total hip replacement. The femoral hip stems and acetabular cup are intended for uncemented fixation and single use implantation. These prostheses may be used for the following conditions, as appropriate:
- Non-inflammatory degenerative joint disease, including osteoarthritis and avascular necrosis; .
- Rheumatoid arthritis;
- Correction of functional deformity: .
- Congenital dislocation; .
- Revision procedures where other treatments or devices have failed; .
- Femoral neck and trochanteric fractures of the proximal femur.
Prescription Use × (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Page 1 of 1
Peter D. Rummer m2 mpf
(Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number__
...